12:00 AM
 | 
Apr 16, 2007
 |  BC Week In Review  |  Company News  |  Deals

Alteon, BioRap Technologies Ltd., Oxis deal

ALT and BioRap expanded a 2005 deal to give ALT rights to all BioRap’s cardiovascular diagnostic technologies. BioRap will receive an upfront payment and research funding and is eligible for milestones and royalties. The original deal included rights to a haptoglobin blood test and a related therapeutic to treat vascular complications and restenosis in Type...

Read the full 261 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >